Consolidated net revenues totaled $372.0 million for the fiscal year Financial condition remains strong with no debt and approximately $30 million in cash Management provides guidance for fiscal year ...
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback